Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 55Active not recruiting 28Completed 27Not yet recruiting 18Withdrawn 2Suspended 2Enrolling by invitation 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1CNS 1Breast 1

Conditions

Sedentary Behavior 1Motor Activity 1Leukemia 1Fatigue 1Breast Neoplasms 1Brain Neoplasms 1Atherosclerosis 1

Interventions

pembrolizumab 19Magnetic Resonance Spectroscopy 13Specimen Handling 12Cyclophosphamide 10fludarabine 9Radiotherapy 9Biopsy 8atezolizumab 7Nivolumab 7Radiation 6Prednisone 4Gemcitabine 4Etoposide 4Cytarabine 4Cisplatin 4Carboplatin 4Blood Specimen Collection 4ALT-803 4lenvatinib 3fludarabine phosphate 3avelumab 3aldesleukin 3X-Rays 3Vincristine 3Surveys and Questionnaires 3Rituximab 3Phantoms, Imaging 3Paclitaxel 3Oxaliplatin 3Lenalidomide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Exercise × 1 year × Clear all
NCT07046481 2025-07-01

Physical Activity and Quality of Life in Childhood Cancersurvivors- a Long-term Follow-up

Region Skane

Phase NA Withdrawn
CNSOther hematologic neoplasm

Brain Neoplasms, Fatigue, Leukemia, Motor Activity, Sedentary Behavior

NCT06852560 2025-06-26

GEM

University of Florida

Phase NA Withdrawn
Breast

Breast Neoplasms, Atherosclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡